QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
Log in
NASDAQ:PETQ

PetIQ Stock Forecast, Price & News

$35.50
+1.93 (+5.75 %)
(As of 02/24/2021 12:00 AM ET)
Add
Compare
Today's Range
$33.59
Now: $35.50
$35.55
50-Day Range
$33.57
MA: $35.49
$37.82
52-Week Range
$15.83
Now: $35.50
$39.29
Volume218,369 shs
Average Volume311,091 shs
Market Capitalization$1.02 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.5
PetIQ, Inc. operates as a pet medication and wellness company. It operates through two segments, Products and Services. The company offers prescription pet medications, including products for arthritis, thyroid, and diabetes and pain treatments, as well as heartworm preventatives, antibiotics, and other specialty medications; and over-the-counter medications and supplies, such as flea and tick control products in various forms comprising spot on treatments, chewables, and collars. It also provides health and wellness products that include dental treats and nutritional supplements, which comprise hip and joint, vitamins, and skin and coat products The company offers its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Advecta, SENTRY, Sergeants, PetLock, Heart Shield Plus, TruProfen, Betsy Farms, PetAction, Minties, Vera, and Delightibles brands. In addition, the company offers a suite of services at community clinics and wellness centers hosted at pet retailers across 41 states, including diagnostic tests, vaccinations, prescription medications, microchipping, and wellness checks. As of March 10, 2020, it operated through approximately 60,000 points of distribution across retail and e-commerce channels. The company was founded in 2010 and is headquartered in Eagle, Idaho.
PetIQ logo

Industry, Sector and Symbol

Industry Drugs, proprietaries, & sundries
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:PETQ
CUSIPN/A
Phone208-939-8900
Employees1,866
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$709.43 million
Cash Flow$1.37 per share
Book Value$11.60 per share

Profitability

Net Income$-11,450,000.00

Miscellaneous

Market Cap$1.02 billion
Next Earnings Date2/25/2021 (Confirmed)
OptionableOptionable

MarketRank

Overall MarketRank

1.58 out of 5 stars

Medical Sector

343rd out of 1,958 stocks

Drugs, Proprietaries, & Sundries Industry

7th out of 14 stocks

Analyst Opinion: 3.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -
$35.50
+1.93 (+5.75 %)
(As of 02/24/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PETQ News and Ratings via Email

Sign-up to receive the latest news and ratings for PETQ and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











PetIQ (NASDAQ:PETQ) Frequently Asked Questions

Is PetIQ a buy right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for PetIQ in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" PetIQ stock.
View analyst ratings for PetIQ
or view top-rated stocks.

What stocks does MarketBeat like better than PetIQ?

Wall Street analysts have given PetIQ a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but PetIQ wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is PetIQ's next earnings date?

PetIQ is scheduled to release its next quarterly earnings announcement on Thursday, February 25th 2021.
View our earnings forecast for PetIQ
.

How can I listen to PetIQ's earnings call?

PetIQ will be holding an earnings conference call on Thursday, February 25th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were PetIQ's earnings last quarter?

PetIQ, Inc. (NASDAQ:PETQ) issued its quarterly earnings data on Tuesday, March, 10th. The company reported ($0.09) EPS for the quarter, missing the consensus estimate of $0.09 by $0.18. The firm earned $154.34 million during the quarter, compared to the consensus estimate of $134.80 million. PetIQ had a negative net margin of 10.13% and a positive trailing twelve-month return on equity of 4.47%.
View PetIQ's earnings history
.

How has PetIQ's stock price been impacted by Coronavirus (COVID-19)?

PetIQ's stock was trading at $22.59 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, PETQ shares have increased by 57.1% and is now trading at $35.50.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for PETQ?

4 equities research analysts have issued twelve-month price objectives for PetIQ's shares. Their forecasts range from $35.00 to $175.00. On average, they anticipate PetIQ's stock price to reach $76.25 in the next twelve months. This suggests a possible upside of 114.8% from the stock's current price.
View analysts' price targets for PetIQ
or view top-rated stocks among Wall Street analysts.

Who are PetIQ's key executives?

PetIQ's management team includes the following people:
  • Mr. McCord Christensen, Chairman & CEO (Age 49)
  • Mr. John Newland, Chief Financial Officer (Age 57)
  • Mr. Michael A. Smith, Exec. VP of Products Division (Age 44, Pay $970.96k)
  • Ms. Susan Sholtis, Pres (Age 55)
  • Mr. Robert Michael Herrman, Gen. Counsel & Sec. (Age 52)
  • Dr. Lauren Olavessen D.V.M., Sr. VP & Chief Medical Officer

What is Cord Christensen's approval rating as PetIQ's CEO?

10 employees have rated PetIQ CEO Cord Christensen on Glassdoor.com. Cord Christensen has an approval rating of 89% among PetIQ's employees.

Who are some of PetIQ's key competitors?

What other stocks do shareholders of PetIQ own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PetIQ investors own include Micron Technology (MU), NVIDIA (NVDA), Advanced Micro Devices (AMD), Alibaba Group (BABA), Exelixis (EXEL), Intel (INTC), CVS Health (CVS), QUALCOMM (QCOM), Editas Medicine (EDIT) and Gilead Sciences (GILD).

When did PetIQ IPO?

(PETQ) raised $86 million in an initial public offering (IPO) on Friday, July 21st 2017. The company issued 5,700,000 shares at $14.00-$16.00 per share. Jefferies and William Blair acted as the underwriters for the IPO and Oppenheimer, Raymond James and SunTrust Robinson Humphrey were co-managers.

What is PetIQ's stock symbol?

PetIQ trades on the NASDAQ under the ticker symbol "PETQ."

Who are PetIQ's major shareholders?

PetIQ's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (7.47%), Russell Investments Group Ltd. (4.50%), Riverbridge Partners LLC (4.23%), Yiheng Capital Management L.P. (2.39%), Thornburg Investment Management Inc. (2.18%) and Peregrine Capital Management LLC (1.60%). Company insiders that own PetIQ stock include James Nathan Clarke, John Newland, Robert Michael Herrman, Susan Sholtis and Will Santana.
View institutional ownership trends for PetIQ
.

Which institutional investors are selling PetIQ stock?

PETQ stock was sold by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Assenagon Asset Management S.A., Peregrine Capital Management LLC, Royce & Associates LP, Rothschild & Co. Asset Management US Inc., AMI Asset Management Corp, Argent Capital Management LLC, and Citigroup Inc.. Company insiders that have sold PetIQ company stock in the last year include John Newland, and Will Santana.
View insider buying and selling activity for PetIQ
or view top insider-selling stocks.

Which institutional investors are buying PetIQ stock?

PETQ stock was purchased by a variety of institutional investors in the last quarter, including Thornburg Investment Management Inc., Riverbridge Partners LLC, Russell Investments Group Ltd., Morgan Stanley, BlackRock Inc., Kiwi Wealth Investments Limited Partnership, First Trust Advisors LP, and Vontobel Holding Ltd.. Company insiders that have bought PetIQ stock in the last two years include James Nathan Clarke, John Newland, and Robert Michael Herrman.
View insider buying and selling activity for PetIQ
or or view top insider-buying stocks.

How do I buy shares of PetIQ?

Shares of PETQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is PetIQ's stock price today?

One share of PETQ stock can currently be purchased for approximately $35.50.

How much money does PetIQ make?

PetIQ has a market capitalization of $1.02 billion and generates $709.43 million in revenue each year. The company earns $-11,450,000.00 in net income (profit) each year or $1.07 on an earnings per share basis.

How many employees does PetIQ have?

PetIQ employs 1,866 workers across the globe.

What is PetIQ's official website?

The official website for PetIQ is www.petiq.com.

Where are PetIQ's headquarters?

PetIQ is headquartered at 923 S. Bridgeway Pl., EAGLE ID, 83616.

How can I contact PetIQ?

PetIQ's mailing address is 923 S. Bridgeway Pl., EAGLE ID, 83616. The company can be reached via phone at 208-939-8900 or via email at [email protected]


This page was last updated on 2/24/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.